1. Home
  2. LGIH vs NVAX Comparison

LGIH vs NVAX Comparison

Compare LGIH & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGIH
  • NVAX
  • Stock Information
  • Founded
  • LGIH 2003
  • NVAX 1987
  • Country
  • LGIH United States
  • NVAX United States
  • Employees
  • LGIH N/A
  • NVAX N/A
  • Industry
  • LGIH Homebuilding
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LGIH Consumer Discretionary
  • NVAX Health Care
  • Exchange
  • LGIH Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • LGIH 1.3B
  • NVAX 1.3B
  • IPO Year
  • LGIH 2013
  • NVAX 1995
  • Fundamental
  • Price
  • LGIH $59.45
  • NVAX $6.67
  • Analyst Decision
  • LGIH Hold
  • NVAX Buy
  • Analyst Count
  • LGIH 4
  • NVAX 6
  • Target Price
  • LGIH $115.00
  • NVAX $17.83
  • AVG Volume (30 Days)
  • LGIH 365.6K
  • NVAX 7.5M
  • Earning Date
  • LGIH 04-29-2025
  • NVAX 05-09-2025
  • Dividend Yield
  • LGIH N/A
  • NVAX N/A
  • EPS Growth
  • LGIH N/A
  • NVAX N/A
  • EPS
  • LGIH 8.30
  • NVAX N/A
  • Revenue
  • LGIH $2,202,598,000.00
  • NVAX $682,162,000.00
  • Revenue This Year
  • LGIH $10.51
  • NVAX $1.07
  • Revenue Next Year
  • LGIH $21.49
  • NVAX N/A
  • P/E Ratio
  • LGIH $7.16
  • NVAX N/A
  • Revenue Growth
  • LGIH N/A
  • NVAX N/A
  • 52 Week Low
  • LGIH $53.13
  • NVAX $3.92
  • 52 Week High
  • LGIH $125.83
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • LGIH 42.88
  • NVAX 49.32
  • Support Level
  • LGIH $53.13
  • NVAX $5.81
  • Resistance Level
  • LGIH $63.64
  • NVAX $7.81
  • Average True Range (ATR)
  • LGIH 4.08
  • NVAX 0.67
  • MACD
  • LGIH 0.80
  • NVAX 0.15
  • Stochastic Oscillator
  • LGIH 45.11
  • NVAX 59.29

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. They have seven operating segments ( Central, Midwest, Southeast, Mid-Atlantic, Northwest, West and Florida divisions) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: